A Pan-cancer Clinical Study of Personalized Neoantigen Vaccine Monotherapy in Treating Patients with Various Types of Advanced Solid Tumors.

导出原文传递

翻译打印收藏纠错

第一作者： Yong,Fang

第一单位： Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

作者： Yong,Fang ^[1] ; Fan,Mo ^[2] ; Jiawei,Shou ^[3] ; Huimin,Wang ^[4] ; Kai,Luo ^[5] ; Shanshan,Zhang ^[1] ; Ning,Han ^[2] ; Hongsen,Li ^[2] ; Shengli,Ye ^[2] ; Zhan,Zhou ^[6] ; Rongchang,Chen ^[2] ; Lin,Chen ^[1] ; Liang,Liu ^[7] ; Huina,Wang ^[3] ; Hongming,Pan ^[2] ; Shuqing,Chen ^[2]

作者单位： Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. ^[1] Hangzhou Neoantigen Therapeutics Co., Ltd., Hangzhou, Zhejiang, China. ^[2] College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China. ^[3] Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. ^[4] Hangzhou AI-Force Therapeutics Co., Ltd., Hangzhou, Zhejiang, China. ^[5] Zhejiang California International Nanosystems Institute, Zhejiang University, Hangzhou, Zhejiang, China. ^[6] Shulan (Hangzhou) Hospital, Hangzhou, Zhejiang, China. ^[7] AcornMed Biotechnology Co., Ltd., Beijing, China. ^[8] Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. chenshuqing@zju.edu.cn panhongming@zju.edu.cn. ^[9] Hangzhou Neoantigen Therapeutics Co., Ltd., Hangzhou, Zhejiang, China. chenshuqing@zju.edu.cn panhongming@zju.edu.cn. ^[10]

主题词抗原, 肿瘤(Antigens, Neoplasm);癌症疫苗(Cancer Vaccines);人类(Humans);免疫疗法(Immunotherapy);肿瘤(Neoplasms);疫苗, 亚单位(Vaccines, Subunit)

DOI 10.1158/1078-0432.CCR-19-2881

PMID 32439700

发布时间 2021-05-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交